• BTK Inhibitors in Multiple Sclerosis Treatment

  • 2025/04/21
  • 再生時間: 21 分
  • ポッドキャスト

BTK Inhibitors in Multiple Sclerosis Treatment

  • サマリー

  • Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.

    Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.

    Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.

    Disclosures can be found at Neurology.org.

    続きを読む 一部表示

あらすじ・解説

Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.

Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.

Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.

Disclosures can be found at Neurology.org.

BTK Inhibitors in Multiple Sclerosis Treatmentに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。